Talkspace TALK
NASDAQ TALK
$5.25 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM EDT

Talkspace (TALK) Non-Current Deffered Revenue (2020 - 2021)

Talkspace's (TALK) quarterly Non-Current Deffered Revenue came in at $14.5 million in Q1 2021, little changed quarter-over-quarter from $14.5 million in Q4 2020.

Analysis

Talkspace (TALK) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends

Talkspace has disclosed Non-Current Deffered Revenue across 2 years of filings, most recently posting $14.5 million for Q1 2021.

  • In Q1 2021, Non-Current Deffered Revenue changed N/A year-over-year to $14.5 million; the TTM figure through Mar 2021 stood at $14.5 million (changed N/A YoY), while the FY2020 annual figure was $14.5 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue came in at $14.5 million for Q1 2021 at Talkspace, roughly flat from $14.5 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $14.5 million in Q2 2020 to a low of $14.5 million in Q2 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn -
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn -
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn -
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn -
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn 9.67 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn -
7 Akso Health 259.44 Mn 259.25 Mn - -
8 LifeMD 147.29 Mn 147.29 Mn - -
9 eHealth 31.71 Mn -69.34 Mn - -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 14.49 Mn
Dec 31, 2020 14.49 Mn
Sep 30, 2020 14.49 Mn
Jun 30, 2020 14.49 Mn